Clinical Trial Update: Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on cytoreductive surgery with HIPEC for first or second-line platinum-resistant recurrent ovarian epithelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Epithelial Cancer

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Ovarian Epithelial Cancer | Phase 3 | Status: UNKNOWN